Inactivation of SARS-CoV-2 Laboratory Specimens.

Haddock, Elaine; Feldmann, Friederike; Shupert, W Lesley; Feldmann, Heinz

Haddock, Elaine; Feldmann, Friederike; Shupert, W Lesley; Feldmann, Heinz.

Haddock E; 1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.
Feldmann F; 2Rocky Mountain Veterinary Branch, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.
Shupert WL; 1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.
Feldmann H; 1Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.

Am J Trop Med Hyg ; 104(6): 2195-2198, 2021 04 20.

Article in English | MEDLINE | ID: covidwho-1194763

ABSTRACT

ABSTRACT

The burden on diagnostic and research laboratories to provide reliable inactivation for biological specimens to allow for safe downstream processing is high during the coronavirus disease 2019 (COVID-19) pandemic. We provide safety data regarding commonly used chemical and physical inactivation procedures that verify their effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Subject(s)

Detergents/pharmacology; Disinfectants/pharmacology; SARS-CoV-2/drug effects; SARS-CoV-2/radiation effects; Virus Inactivation; Humans; Laboratories; RNA, Viral/physiology; Specimen Handling/methods

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Virus Inactivation / Detergents / Disinfectants / SARS-CoV-2 Limits: Humans Language: English Journal: Am J Trop Med Hyg Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google